Results 1 to 10 of about 404,157 (168)

Interaction of Proteins Involved in Neuronal Proteinopathies

open access: yesLife, 2023
Proteinopathy is characterized by the accumulation of aggregates of a specific protein in a target organ, tissue, or cell. The aggregation of the same protein can cause different pathologies as single protein can adopt various amyloidogenic, disease ...
Konstantin Y. Kulichikhin   +4 more
doaj   +1 more source

Ubiquitous Amyloids [PDF]

open access: yesApplied Biochemistry and Biotechnology, 2012
The common view of amyloids and prion proteins is that they are associated with many currently incurable diseases and present a great danger to an organism. This danger comes from the fact that not only prion proteins, but also the infectious form(s) of amyloids, as it has been shown recently, are able to transmit the disease.
Pulawski W   +3 more
openaire   +2 more sources

AmyloGraph: a comprehensive database of amyloid–amyloid interactions

open access: yesNucleic Acids Research, 2022
Abstract Information about the impact of interactions between amyloid proteins on their fibrillization propensity is scattered among many experimental articles and presented in unstructured form. We manually curated information located in almost 200 publications (selected out of 562 initially considered), obtaining details of 883 ...
Michal Burdukiewicz   +14 more
openaire   +4 more sources

Functional Mammalian Amyloids and Amyloid-Like Proteins

open access: yesLife, 2020
Amyloids are highly ordered fibrous cross-β protein aggregates that are notorious primarily because of association with a variety of incurable human and animal diseases (termed amyloidoses), including Alzheimer’s disease (AD), Parkinson’s disease (PD ...
Maria S. Rubel   +6 more
doaj   +1 more source

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis

open access: yeseJHaem, 2022
The causal protein of amyloid light‐chain (AL) amyloidosis is a monoclonal immunoglobulin free light chain (mFLC), which must be quantified in the serum for patient diagnosis and monitoring.
Hajer Abroud   +18 more
doaj   +1 more source

Amyloid cardiomyopathy [PDF]

open access: yesBiomedical Papers, 2017
Amyloidosis is a heterogeneous group of diseases characterized by the deposition of amyloid. It is caused by extracellular deposition of insoluble fibrils with beta-pleated sheet configuration. The protein misfolding abnormalities result in amyloid fibrils and may manifest as primary, secondary, or familial amyloidosis.
Lucie Karafiatova, Tomas Pika
openaire   +3 more sources

Microbial amyloids in neurodegenerative amyloid diseases

open access: yesThe FEBS Journal, 2023
Human‐disease associated amyloidogenic proteins are not unique in their ability to form amyloid fibrillar structures. Numerous microbes produce amyloidogenic proteins that have distinct functions for their physiology in their amyloid form, rather than solely detrimental. Emerging data indicate associations between various microbial organisms, including
openaire   +2 more sources

An Efficient Method for Isolation of Plasmid DNA for Transfection of Mammalian Cell Cultures

open access: yesMethods and Protocols, 2020
In this article, we present several protocols that describe the steps from cloning and obtaining a large amount of pure plasmid DNA to generation of lentiviruses based on these constructs.
Daniel V. Kachkin   +3 more
doaj   +1 more source

Implementing a Machine-Learning-Adapted Algorithm to Identify Possible Transthyretin Amyloid Cardiomyopathy at an Academic Medical Center

open access: yesClinical Medicine Insights: Cardiology, 2022
Background: Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is a frequently under-recognized cause of heart failure (HF) in older patients. To improve identification of patients at risk for the disease, we initiated a pilot program in which 9 ...
Joshua D Mitchell   +6 more
doaj   +1 more source

Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2020
Background: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive and irreversible loss of cognitive function. The presence of senile plaques is one of the pathological markers of the disease and is associated with the ...
Júlia Canto e SOUSA   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy